Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/current-and-future-immunosuppressive-therapies-following-transplantation/sayegh/descriptif_1775359
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=1775359

Current and Future Immunosuppressive Therapies Following Transplantation, 2001

Langue : Anglais

Coordonnateur : Remuzzi Giuseppe

Couverture de l’ouvrage Current and Future Immunosuppressive Therapies Following Transplantation
This title provides a comprehensive and state-of-the-art summary of current and future immunosuppressive strategies in transplantation, with emphasis on the basic science mechanisms and clinical applicability of these strategies. The uniqueness of this book is the inclusion of up-to-date information on the basic mechanisms of actions of the immunosuppressive drugs as well as a summary of the clinical trials data and the potential use of these drugs in clinical organ transplantation. In addition to describing the various immunosuppressive strategies, the book has three special features, including immunosuppression in xenotransplantation, gene therapy approaches, and transplantation tolerance. A group of outstanding investigators have been assembled to write the chapters. The book is intended for the transplant professional and the specialist who wants to stay abreast of the current status of immunosuppression in organ transplantation. The book is also useful for basic scientists who work in the field of transplantation immunology.
Contributors List. I: Introduction. 1. The History of Immunosuppression for Ogan Transplantation; J.C. Hong, B.D. Kahan. 2. Clinical Trials in Transplant Immunosuppression: What Have We Learned? P. Schnuelle, F.J. van der Woude. II: Pharmacological Immunosuppression. 1. Pharmacologic Monitoring of Immunosuppressive Drugs; F. Gaspari, et al. 2. Use of Corticosteroids in Kidney Transplantation; D.E. Hricik. 3. Mycophenolate Mofetil and Azathioprine; J.D. Pirsch, E.D. Neto. 4. Cyclosporine Formulations; V. Ramanathan, H. Helderman. 5. Tacrolimus; R. Shapiro. 6. Sirolimus; B.D. Kahan. 7. New Agents on the Horizon; J. Klupp, R.E. Morris. III: Biologicals. 1. Why Do We Need Induction Therapy? J. Vella, J. Neylan. 2. Polyclonal Antilymphocyte Therapy; P. Morrissey, A.P. Monaco. 3. Monoclonal Antibody Targeting of the T cell Receptor Complex; L. Chatenoud. 4. Monoclonal Antibody Targeting of IL-2R-Complex; F.G. Vincenti. 5. Monoclonal Antibody Targeting of Adhesion Molecules; M.H. Frank, D.M. Briscoe. 6. Costimulation Blocade; R.D. Bloom, L.A. Turka. 7. Immunomodulatory Function of MHC Peptides; B. Murphy, A. Krensky. 8. Tolerance: Is It Time to Move to the Clinic? M.H. Frank, M.H. Sayegh. IV: Gene Therapy. 1. Molecular Medicine in Organ Transplantation: How and When? A. Benigni, et al. 2. Gene Therapy in Organ Transplantation: Applicabilities andShortcomings; J.C. Magee, et al. 3. Immunomodulation Strategies in Xenotransplantation; I.P.J. Alwayn, et al.

Date de parution :

Ouvrage de 388 p.

16x24 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

158,24 €

Ajouter au panier

Date de parution :

Ouvrage de 388 p.

15.5x23.5 cm

Sous réserve de disponibilité chez l'éditeur.

158,24 €

Ajouter au panier